Skip to main content
Signal8

THULIN INGE G

SEC insider (Form 3/4/5 filer). CIK 0001263739. Director at Merck & Co., Inc. (MRK). 3 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in RAHWAY, NJ.

Companies THULIN INGE G has filed insider reports for

  • Merck & Co., Inc. (MRK): Director
THULIN INGE G profile photo

THULIN INGE G

CIK: 0001263739

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Merck & Co., Inc. logo
MRK

Merck & Co., Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Merck & Co., Inc. logo
    MRK

    Merck & Co., Inc.

    May 29, 2026
    Award

    Phantom Stock

    Direct
    1.9K shares at avg. $118.72-
  • Merck & Co., Inc. logo
    MRK

    Merck & Co., Inc.

    May 30, 2025
    Award

    Phantom Stock

    Direct
    2.9K shares at avg. $76.84-
  • Merck & Co., Inc. logo
    MRK

    Merck & Co., Inc.

    Feb 6, 2025
    Purchase
    Direct
    2.8K shares at avg. $88.25$250K

1-3 of 3